 Patients are routinely asked to sign an informed consent document prior to starting chemotherapy, indicating they understand the risks and benefits of treatment. Although this could be a strategic moment to equip patients with information they need to make truly informed medical decisions, many patients and caregivers note that these conversations are less useful than they could be. The informed consent process and its associated documents suffer several limitations: 1 risks are emphasized over benefits; 2 educational materials focus on individual drugs instead of regimens; 3 information is presented in written instead of alternative writtenaudiovisual format; and 4 the patient perspective is lacking. 